
Organogenesis Holdings Inc.
ORGOHealthcare|Drug Manufacturers - Specialty & Generic|US
$0.81
-0.03 (-3.18%)
DCF Value
$3.83
Tangible Book / Share
$1.79
Cash / Share
$0.17
Next Earnings Report
Mar 4, 2027
EPS est. -$0.14 · Revenue est. $63.0M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Aug 6, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Apr 2029
Est. completion
NAVenous Leg Ulcers
Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous Leg Ulcers (VLUs)
NCT07510412n=200
Recent Press Releases
Organogenesis Holdings Inc. Reports Third Quarter 2026 Financial Results
Nov 5, 2026 · GlobeNewsWire
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
Oct 12, 2026 · GlobeNewsWire
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Oct 12, 2026 · GlobeNewsWire
SEC Filings (51)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Nov 5, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Aug 6, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Jun 16, 2026 | 8-K | Material event | DocumentIndex |
| May 7, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 30, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 30, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Feb 26, 2026 | 10-K | Annual report | DocumentIndex |
| Feb 26, 2026 | 8-K | Material event | DocumentIndex |
| Feb 23, 2026 | 8-K | Material event | DocumentIndex |
| Feb 17, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Feb 12, 2026 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Dec 29, 2025 | 8-K | Material event | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Nov 3, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 25, 2025 | 8-K | Material event | DocumentIndex |
| Aug 14, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 7, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2025 | 8-K | Material event | DocumentIndex |
| Jun 26, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jun 24, 2025 | 8-K | Material event | DocumentIndex |
| May 12, 2025 | ARS | Annual report to holders | DocumentIndex |
| May 12, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 8, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 8, 2025 | 8-K | Material event | DocumentIndex |
| Apr 29, 2025 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2025 | 10-K/A | Annual report | DocumentIndex |
| Mar 27, 2025 | 8-K | Material event | DocumentIndex |
| Feb 27, 2025 | 10-K | Annual report | DocumentIndex |
| Feb 27, 2025 | 8-K | Material event | DocumentIndex |
| Feb 11, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jan 13, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Jan 3, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Dec 23, 2024 | 424B3 | Offering prospectus | DocumentIndex |